Chief clinical development officer of HMNC Brain Health, Hans Eriksson, speaks to Psychedelic Health about how the company’s formula, ‘Ketabon’, will provide the therapeutic benefits of ketamine without the ‘trip.’
— Read on psychedelichealth.co.uk/2022/10/03/hmnc-ketamine-treatment-first-class-patients/amp/